We examined the number of admissions per patient during the studied period versus the number of correct regimens. Although larger sample sizes would be needed to detect

any statistically significant correlation, the study YAP-TEAD Inhibitor 1 results demonstrated comparable accuracy rates with an average of less than 50 percent regardless of the number of admissions accrued per patient. All patients should have been on three, four or five ART drugs based on clinic records. The percentage of correct regimens initially prescribed was lowest in those with five ART drugs. The use of fixed-dose combination ART medications has been demonstrated to produce positive outcomes through reduced pill burden and increased compliance [20]. In our study, it is not known if patients on fixed-dose combination pills tended to have better outcomes. The increasing complexity of

HAART regimens and corresponding limitations in prescriber knowledge could have contributed to the high percentage of incorrect regimens found to be initially prescribed in our study. Purdy and colleagues [11] demonstrated this in an earlier study. They identified 108 clinically significant prescribing errors over a 34-month period, with the major error-related factor being confusion or lack of familiarity with appropriate dosing (30.3%). The majority of admissions in our study were by specialists in internal medicine/non-ID, the specialties that probably had the heaviest patient census. Dynein Previous studies demonstrated that admission by a non-ID specialist was an independent

Ceritinib risk factor for drug-related issues and having designated ID/HIV specialists led to significant improvements in the ART prescribing process [8, 13, 14, 17-19]. As our study focused on the initial prescribing of ART medications, subsequent beneficial interventions that could have been made by specially trained providers were not evaluated, such as dosing modifications as a result of renal or hepatic impairment. After the completion of this study, a specific process was implemented at our institution to enhance utilization of ID specialists and clinical pharmacists during the medication reconciliation process for hospitalized clinic HIV-infected patients. Future studies are needed to evaluate the clinical impact of this process. Multiple factors related to data collection could have potentially influenced the study outcome, including incomplete documentation and investigator bias during chart review when determining what should be considered an appropriate interruption. However, the findings of this and previous studies clearly demonstrate that medication reconciliation and accurate prescribing remain a challenge in the area of HIV infection management.